Draft:Lynn A. Cunningham
Submission declined on 15 August 2024 by DoubleGrazing (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
| ![]() |
Lynn A. Cunningham is an American psychiatrist whose work helped increase our understanding of the efficacy of antidepressant medication.[1][2] His research also helped create better understanding regarding the impact that side effects can have in effectively matching patients with viable treatment agents.[3]
- ^ Cunningham, Lynn (1997-09-01). "Once-Daily Venlafaxine Extended Release (XR) and Venlafaxine Immediate Release (IR) in Outpatients with Major Depression". Annals of Clinical Psychiatry. 9 (3): 157–164. doi:10.3109/10401239709147791. ISSN 1040-1237.
- ^ Cunningham, Lynn A.; Borison, Richard L.; Carman, John S.; Chouinard, Guy; Crowder, John E.; Diamond, Bruce I.; Fischer, Daniel E.; Hearst, Earl (April 1994). "A Comparison of Venlafaxine, Trazodone, and Placebo in Major Depression". Journal of Clinical Psychopharmacology. 14 (2): 99–106. doi:10.1097/00004714-199404000-00003. ISSN 0271-0749. PMID 8195464.
- ^ Coleman, Charles; Cunningham, Lynn; Foster, Vicki; Batey, Sharyn; Donahue, Rafe; Houser, Trisha; Ascher, John (1999-12-01). "Sexual Dysfunction Associated with the Treatment of Depression: A Placebo-Controlled Comparison of Bupropion Sustained Release and Sertraline Treatment". Annals of Clinical Psychiatry. 11 (4): 205–215. doi:10.3109/10401239909147072. ISSN 1040-1237. PMID 10596735.